regadenoson has been researched along with Sensitivity and Specificity in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 24 (96.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aulwes, D; Gupta, D; Holly, TA; Montero, K; Ross, MI; Shen, S; Wilkins, JT; Wu, E | 1 |
| Alam, M; Ananthasubramaniam, K; Boedeker, S; Brooks, K; Iyer, H; Khandelwal, A; Nguyen, P; Saad, H; Shaikh, K; Wang, DD | 1 |
| Al-Amoodi, M; Ballany, W; Doukky, R; Mansour, K; Morales Demori, R | 1 |
| Cerqueira, MD; Cremer, PC; Jaber, WA; Khalaf, S; Lou, J; Rodriguez, L | 1 |
| Bayer, RR; De Cecco, CN; Harris, BS; Krazinski, AW; McWhite, CB; Meinel, FG; Schoepf, UJ; Silverman, JR | 1 |
| Bateman, TM; Cerqueira, MD; Iskandrian, AE; Mahmarian, JJ; Nabi, F; Peterson, LE; Thomas, GS; Xu, J | 1 |
| Bleich, S; El-Hajj, S; Ghimire, G; Hage, FG; Iskandrian, AE; Lester, D; Mckay, J | 1 |
| Dilsizian, V; Narula, J | 1 |
| Confer, K; Doukky, R; Fughhi, I; Mansour, K; Nigatu, A; Olusanya, A; Saini, A; Sims, SA; Vashistha, R | 1 |
| Borges-Neto, S; Dunning, A; Farzaneh-Far, A; O'Connor, CM; Oldan, JD; Shaw, LK | 1 |
| AlJaroudi, WA; Bleich, S; El-Hajj, S; Farag, A; Hage, FG; Iskandrian, AE; Manaoragada, P | 1 |
| Bhambhvani, P; El-Hajj, S; Farag, AA; Hage, FG; Heo, J; Iskandrian, AE; Lester, D; Tauxe, L | 1 |
| Bordenave, L; Douard, H; Janvier, L; Karcher, G; Pinaquy, J | 1 |
| Ali, A; Campagnoli, T; Doukky, R; Fughhi, I; Wassouf, M | 1 |
| Bhave, NM; Chandra, S; Freed, BH; Kachenoura, N; Lang, RM; Lodato, JA; Maffessanti, F; Mor-Avi, V; Patel, AR; Port, S | 1 |
| Abdallah, M; Dwivedi, A; Gerson, MC; Jameria, ZA; Kalakota, N; Khaleghi, M; Khan, N; Washburn, E | 1 |
| Berman, D; Brodov, Y; Fish, M; Gerlach, J; Germano, G; Gransar, H; Lemley, M; Otaki, Y; Rubeaux, M; Slomka, P | 1 |
| Ananthasubramaniam, K; Cullom, SJ; Feaheny, KM; Gropler, RJ; Jain, D; Kitt, TM; Thomas, GS; Thompson, RC | 1 |
| Franks, B; Iskandrian, AE; McNutt, BE; Tejani, FH; Thompson, RC | 1 |
| Dean, P; Hage, FG; Heo, J; Iqbal, F; Iskandrian, AE | 1 |
| Giedd, KN; Katz, JS; Rachko, M; Ruisi, M | 1 |
| Ahlberg, AW; Ardestani, A; Barmpouletos, D; Borer, SM; Cyr, G; Heller, GV; Iyah, GS; Katten, DM; Mathur, S; Morales, DC; Parker, MW; Slim, HB | 1 |
| Ghimire, G; Hage, FG; Heo, J; Iskandrian, AE | 1 |
| Al-Amoodi, M; Bateman, TM; Bybee, KA; Iain McGhie, A; Kennedy, KF; O'Keefe, JH; Oakes, L; Patil, H; Thomas, GS; Thompson, EC; Thompson, RC | 1 |
| Eggbrecht, H; Gössl, M | 1 |
1 review(s) available for regadenoson and Sensitivity and Specificity
| Article | Year |
|---|---|
Regadenoson: a focused update.
Topics: Coronary Artery Disease; Evidence-Based Medicine; Exercise Test; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2013 |
9 trial(s) available for regadenoson and Sensitivity and Specificity
| Article | Year |
|---|---|
Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.
Topics: Adenosine A2 Receptor Agonists; Adult; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Male; Myocardial Perfusion Imaging; Physical Endurance; Physical Exertion; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2013 |
The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
Topics: Adenosine A2 Receptor Agonists; Aminophylline; Cardiotonic Agents; Double-Blind Method; Exercise Test; Female; Humans; Hyperemia; Image Enhancement; Male; Middle Aged; Myocardial Perfusion Imaging; Placebo Effect; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |
Stress positron emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement.
Topics: Aged; Aortic Valve Stenosis; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Positron-Emission Tomography; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Transcatheter Aortic Valve Replacement; Vasodilator Agents | 2014 |
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Coronary Artery Disease; Double-Blind Method; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2015 |
A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.
Topics: Aged; Coronary Artery Disease; Exercise Test; Female; Hand Strength; Humans; Image Enhancement; Isometric Contraction; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2017 |
The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exerc
Topics: Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; United States; Vasodilator Agents | 2017 |
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Adult; Aged; Aged, 80 and over; Caffeine; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Central Nervous System Stimulants; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; United States; Young Adult | 2011 |
A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2013 |
Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise.
Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Physical Endurance; Prevalence; Purines; Pyrazoles; Reproducibility of Results; Rest; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Walking | 2013 |
15 other study(ies) available for regadenoson and Sensitivity and Specificity
| Article | Year |
|---|---|
Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.
Topics: Adenosine A2 Receptor Agonists; Anti-Arrhythmia Agents; Atropine; Coronary Angiography; Coronary Artery Disease; Dyspnea; Echocardiography, Stress; Feasibility Studies; Female; Headache; Humans; Male; Middle Aged; Patient Satisfaction; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires | 2014 |
Incremental value of pharmacological stress cardiac dual-energy CT over coronary CT angiography alone for the assessment of coronary artery disease in a high-risk population.
Topics: Adenosine; Cardiac Catheterization; Cardiac-Gated Imaging Techniques; Contrast Media; Coronary Angiography; Coronary Artery Disease; Exercise Test; Female; Humans; Iopamidol; Male; Middle Aged; Prospective Studies; Purines; Pyrazoles; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
The prognostic value of regadenoson myocardial perfusion imaging.
Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; United States | 2015 |
Capturing maximal coronary vasodilation for myocardial perfusion imaging: is timing everything?
Topics: Adenosine A2 Receptor Agonists; Dipyridamole; Humans; Hyperemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilation; Vasodilator Agents | 2015 |
Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging.
Topics: Adenosine A2 Receptor Agonists; Chicago; Electrocardiography; Exercise Test; Female; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon | 2015 |
Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.
Topics: Adenosine; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; North Carolina; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Vasodilator Agents | 2015 |
Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
Topics: Alabama; Comorbidity; Contrast Media; Coronary Artery Disease; Exercise Test; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Vasodilator Agents | 2016 |
Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.
Topics: Exercise Test; Humans; Hypertrophy, Left Ventricular; Image Enhancement; Myocardial Ischemia; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2016 |
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
Topics: Age Distribution; Cardio-Renal Syndrome; Chicago; Comorbidity; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Single-Blind Method; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2017 |
Three-dimensional quantification of myocardial perfusion during regadenoson stress computed tomography.
Topics: Arterial Occlusive Diseases; Coronary Angiography; Coronary Vessels; Female; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Vasodilator Agents | 2016 |
Computer derived transient ischemic dilation ratio for identifying extensive coronary artery disease using a CZT camera and imaging in the upright position.
Topics: Aged; Cadmium; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diagnosis, Computer-Assisted; Dilatation; Exercise Test; Female; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Ischemia; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tellurium; Tomography, Emission-Computed, Single-Photon; Zinc | 2017 |
Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99m high-efficiency SPECT.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2016 |
A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.
Topics: Adenosine A2 Receptor Antagonists; Alabama; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2011 |
Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
Topics: Adenosine A2 Receptor Agonists; Aged; Aged, 80 and over; Angiography; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Software; Tomography, Emission-Computed, Single-Photon | 2012 |
Regadenoson (CV Therapeutics/Astellas).
Topics: Adenosine A2 Receptor Agonists; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Humans; Purines; Pyrazoles; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilation; Vasodilator Agents | 2006 |